Solventum Corporation

NYSE:SOLV

Medical - Care Facilities

Healthcare
$86.48 -2.61%

-$2.00 today

Market cap
$14.70B
Beta
0.75
P/E (TTM)
9.1
EPS (TTM)
$8.22
52W Low $62.38High $88.20

Volume 0.76M

Average 1.70M

SOLV Selling, General & Admin

Overhead costs of running the business, including sales, marketing, management, and administrative staff.

Solventum CorporationNYSE: SOLV

Selling, General & Admin · Q2 FY2026 · quarter ended Jun 2026

Selling, general & admin growth accelerates

Q2 FY2026 selling, general & admin of $927M rose 20.1% year over year, ahead of the +8.8% change in trailing-twelve-month selling, general & admin. Sequentially, it rose 12.1% from the prior quarter. Over 3 fiscal years it compounded at +11.3% a year.

Context

  • Selling, general & admin amounted to 37.0% of revenue in FY2025, up 3.3 pp from a year earlier.
  • Selling, general & admin increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether selling, general & admin reaches the consensus estimate from 11 analysts of $2.53B (-17.8%) for the fiscal year ending Dec 2026, a slowdown from the +10.7% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJun 2026
$927M+12.1% QoQ
Last fiscal yearDec 2025
$3.08B+10.7% YoY
LTMJun 2026
$3.29B+8.8% YoY
Selling, General & Admin past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+20.1%-24.0%-44.1 pp
1 year+10.7%-17.8%-28.5 pp
3-year CAGR+11.3%-3.8%-15.1 pp
5-year CAGR-0.8%—
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Selling, General & Admin history

USD · from the income statement

Latest · FY2025
3.08B USD
Year-over-year change
+10.7%
4-year CAGR
+7.8%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Selling, General & Admin vs competitors

How SOLV compares with its peers on the latest reported figures

  • SOLV's LTM Jun 2026 selling, general & admin of $3.29B is the 2nd highest of the 10 companies compared; the peer median is $1.44B.
  • Its year-over-year change of +8.8% is the 3rd highest of 10, against a peer median of -0.1%.
  • Selling, general & admin amounts to 39.6% of revenue for SOLV, versus a peer median of 28.5%.
SOLV Competitors Peer median
Selling, General & Admin for SOLV and competitors
Company Period LTM YoY 3-year CAGR% of revenue
BDXBecton, Dickinson and CompanyLTM Sep 2026$5.17B -2.1%+1.7%25.6%
SOLVSolventum CorporationLTM Jun 2026$3.29B +8.8%+11.3%39.6%
HSICHenry Schein, Inc.LTM Jun 2026$3.2B +7.6%+4.4%23.5%
BAXBaxter International Inc.LTM Jun 2026$2.93B -0.1%-2.3%25.6%
COOThe Cooper Companies, Inc.LTM Jul 2026$1.89B +17.9%+6.6%44.5%
XRAYDENTSPLY SIRONA Inc.LTM Mar 2026$1.44B -7.1%-3.3%39.0%
NVSTEnvista Holdings CorpLTM Oct 2026$1.18B +5.3%+4.0%41.1%
ICUIICU Medical, Inc.LTM Jun 2026$615.07M -3.6%+0.9%28.5%
MMSIMerit Medical Systems, Inc.LTM Sep 2026$481.78M +9.7%+9.9%29.9%
UTMDUtah Medical Products, Inc.LTM Mar 2026$8.65M -32.6%-13.1%23.0%
Peer median (excluding SOLV) $1.44B-0.1%+1.7%28.5%

Competitors are the stored peer set for SOLV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue8.17B8.13B8.2B8.25B8.33B
Cost of Revenue3.25B3.44B3.5B3.66B3.87B
Gross Profit4.92B4.7B4.69B4.59B4.45B
Gross Margin60.2%57.7%57.3%55.6%53.5%
Research & Development766M767M758M775M739M
Selling, General & Admin2.28B2.24B2.24B2.78B3.08B
Operating Expenses3.04B3B3B3.56B2.27B
Depreciation & Amortization597M578M561M555M489M
EBITDA2.48B2.27B2.23B1.53B2.55B
EBITDA Margin30.3%27.9%27.2%18.5%30.6%
Operating Income1.88B1.69B1.69B1.04B2.18B
Operating Margin23.0%20.8%20.6%12.6%26.2%
Interest Income00000
Interest Expense000367M347M
Other Income / Expenses3M(1M)(25M)(431M)(468M)
Income Before Tax1.88B1.69B1.67B605M1.71B
Pre-Tax Margin23.0%20.8%20.3%7.3%20.6%
Income Tax Expense422M349M321M127M157M
Net Income1.46B1.34B1.35B479M1.56B
Net Margin17.9%16.5%16.4%5.8%18.7%
EPS (Basic)8.477.797.792.778.94
EPS (Diluted)8.477.797.792.768.88
Weighted Avg Shares172.47M172.47M172.71M173.2M174.1M
Weighted Avg Shares (Diluted)172.47M172.47M172.71M173.7M175.3M

Solventum Corporation

NYSE:SOLV

Intrinsic Alpha fair value

Locked

Current Price

$86.48

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.